Targeting the Primordial Chaperone to Overcome Acquired Drug Resistance in Cancer: TG2-Mediated Autophagy.

Biomol Ther (Seoul) · 2026 · PMC12782871 · PMID 41490984

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Even focusing only on the tumor suppressors identified so far that bind to the TG2 N-terminus, these are highly significant targets.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.